Circ_0053943 complexed with IGF2BP3 drives uveal melanoma progression via regulating N6-methyladenosine modification of Epidermal growth factor receptor
Oncology Research · 2024
DOI: 10.32604/or.2024.045972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2024. Verfasst von Andi Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China. Hauptthemen laut MEDLINE: RNA, Circular, Uveal Neoplasms, ErbB Receptors, RNA-Binding Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China.
- The First Clinical Medical College, Nanjing Medical University, Nanjing, 211166, China.
- Department of Ophthalmology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Zitieren
APA
Zhao, A., Wang, Y., Wang, Z., Shao, Q., Gong, Q. I., Zhu, H., Shen, S., Liu, H. U., & Chen, X. (2024). Circ_0053943 complexed with IGF2BP3 drives uveal melanoma progression via regulating N6-methyladenosine modification of Epidermal growth factor receptor. Oncology Research. https://doi.org/10.32604/or.2024.045972
Vancouver
Zhao A, Wang Y, Wang Z, Shao Q, Gong QI, Zhu H, et al. Circ_0053943 complexed with IGF2BP3 drives uveal melanoma progression via regulating N6-methyladenosine modification of Epidermal growth factor receptor. Oncology Research. 2024. doi:10.32604/or.2024.045972
BibTeX
@article{Zhao2024,
author = {Zhao, Andi and Wang, Yue and Wang, Zijin and Shao, Qing and Gong, Q I and Zhu, Hui and Shen, Shiya and Liu, H U and Chen, Xuejuan},
title = {Circ_0053943 complexed with IGF2BP3 drives uveal melanoma progression via regulating N6-methyladenosine modification of Epidermal growth factor receptor},
journal = {Oncology Research},
year = {2024},
doi = {10.32604/or.2024.045972}
}
EUVIMED